Ron Bentsur
2009 - Keryx Biopharmaceuticals
In 2009, Ron Bentsur earned a total compensation of $727.9K as Chief Executive Officer at Keryx Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $111,456 |
|---|---|
| Option Awards | $176,340 |
| Salary | $183,750 |
| Stock Awards | $236,000 |
| Other | $20,349 |
| Total | $727,895 |
Bentsur received $236K in stock awards, accounting for 32% of the total pay in 2009.
Bentsur also received $111.5K in non-equity incentive plan, $176.3K in option awards, $183.8K in salary and $20.3K in other compensation.
Rankings
In 2009, Ron Bentsur's compensation ranked 5,531st out of 9,885 executives tracked by ExecPay. In other words, Bentsur earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,531 out of 9,885 | 44th |
Division Manufacturing | 1,988 out of 3,690 | 46th |
Major group Chemicals And Allied Products | 415 out of 871 | 52nd |
Industry group Drugs | 268 out of 643 | 58th |
Industry Pharmaceutical Preparations | 201 out of 446 | 55th |
Source: SEC filing on April 30, 2012.
Bentsur's colleagues
We found three more compensation records of executives who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2009.